|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.340 USD | -0.41% |
|
+1.24% | +4.26% |
| 12-20 | Lifestance Health Group Insider Sold Shares Worth $345,000, According to a Recent SEC Filing | MT |
| 12-09 | Barclays Initiates Lifestance Health With Overweight Rating, $8 Price Target | MT |
| Capitalization | 2.86B 2.43B 2.25B 2.1B 3.92B 262B 4.16B 25.72B 10.21B 124B 10.71B 10.49B 451B | P/E ratio 2025 * |
-2,000x | P/E ratio 2026 * | 165x |
|---|---|---|---|---|---|
| Enterprise value | 2.91B 2.47B 2.29B 2.14B 3.99B 267B 4.23B 26.21B 10.4B 126B 10.91B 10.68B 459B | EV / Sales 2025 * |
2.05x | EV / Sales 2026 * | 1.72x |
| Free-Float |
31.24% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: LifeStance Health Group, Inc.
| 1 day | -0.41% | ||
| 1 week | +1.24% | ||
| Current month | +4.26% | ||
| 1 month | +3.97% | ||
| 3 months | +42.80% | ||
| 6 months | +71.90% | ||
| Current year | +4.26% |
| 1 week | 7.02 |  | 7.46 |
| 1 month | 6.76 | | 7.52 |
| Current year | 6.76 | | 7.52 |
| 1 year | 3.74 | | 8.3 |
| 3 years | 3.74 | | 9.59 |
| 5 years | 3.74 | | 29.81 |
| 10 years | 3.74 | | 29.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Bourdon
CEO | Chief Executive Officer | 57 | 03/03/2025 |
Ujjwal Ramtekkar
CTO | Chief Tech/Sci/R&D Officer | 44 | 22/01/2024 |
Vaughn Paunovich
CTO | Chief Tech/Sci/R&D Officer | - | 09/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bessler
BRD | Director/Board Member | 53 | 01/01/2017 |
Darren Black
BRD | Director/Board Member | 53 | 01/01/2017 |
Jeffrey Rhodes
BRD | Director/Board Member | 51 | 01/05/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.78% | 0.01% | 300 M€ | |
| +7.39% | 0% | 7 M€ | |
| +3.76% | 0% | 50 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.41% | +1.24% | -8.14% | +39.81% | 2.86B | |
| +0.97% | +0.34% | +44.73% | +78.49% | 107B | |
| +0.40% | +5.61% | +54.24% | -4.81% | 105B | |
| -0.21% | -2.93% | +31.44% | +71.83% | 32.03B | |
| +1.52% | +3.01% | -8.56% | +17.21% | 24.92B | |
| -1.23% | -1.55% | +9.14% | +3.42% | 22.11B | |
| -0.63% | -4.47% | +19.21% | +23.13% | 20.14B | |
| +1.29% | +9.19% | +58.72% | +55.03% | 18.33B | |
| -0.35% | -4.05% | +36.51% | +266.56% | 16.59B | |
| -0.30% | +2.61% | +8.00% | +38.19% | 12.81B | |
| Average | +0.11% | +0.60% | +24.53% | +58.89% | 36.26B | |
| Weighted average by Cap. | +0.41% | +0.60% | +37.68% | +47.53% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.42B 1.21B 1.12B 1.05B 1.95B 131B 2.07B 12.8B 5.08B 61.62B 5.33B 5.22B 224B | 1.62B 1.38B 1.28B 1.2B 2.23B 149B 2.36B 14.63B 5.81B 70.43B 6.09B 5.96B 256B |
| Net income | -2.03M -1.73M -1.6M -1.5M -2.79M -187M -2.96M -18.31M -7.27M -88.16M -7.62M -7.46M -321M | 17.37M 14.77M 13.69M 12.8M 23.86M 1.6B 25.29M 157M 62.13M 754M 65.14M 63.8M 2.74B |
| Net Debt | 53.54M 45.54M 42.21M 39.44M 73.53M 4.92B 77.94M 482M 192M 2.32B 201M 197M 8.45B | -54.86M -46.66M -43.25M -40.41M -75.34M -5.04B -79.86M -494M -196M -2.38B -206M -202M -8.66B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/01/26 | 7.340 $ | -0.41% | 1,333,518 |
| 22/01/26 | 7.370 $ | +2.22% | 1,554,506 |
| 21/01/26 | 7.210 $ | +0.42% | 1,675,475 |
| 20/01/26 | 7.180 $ | -0.97% | 1,314,772 |
| 16/01/26 | 7.250 $ | -2.55% | 1,659,768 |
Delayed Quote Nasdaq, January 24, 2026 at 12:00 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LFST Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition